Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
MGNX
#3182
MacroGenics, Inc.
1.9
9
+1.53%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+1.53%
Changement Mensuel
+8.15%
Evolution sur 6 mois
+13.71%
Changement Annuel
-17.43%
Clôture Précédente
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
Volume
16
Marchés
Actions des Marchés US
Soins de Santé
MGNX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
62.76 M
63.09 M
63.09 M
63.21 M
63.26 M
—
Valuation ratios
Enterprise value
26.87 M
22.2 M
-65.45 M
-54.21 M
26.15 M
-71.3 M
Price to earnings ratio
-2.1
-3.04
-1.44
-2.16
-1.41
-8.05
Price to sales ratio
1.46
1.36
0.52
0.46
0.83
3.17
Price to cash flow ratio
-3.51
-2.98
-1.14
-1.06
-0.65
-5.83
Price to book ratio
0.47
1.75
0.21
0.21
0.34
2.52
Enterprise value to EBITDA ratio
0.29
0.26
-0.7
-0.49
0.34
-0.59
Profitability ratios
Return on assets %
0.21
-0.37
0.18
0.15
0.06
0.02
Return on equity %
0.47
-0.84
0.52
0.78
0.25
0.71
Return on invested capital %
—
-2 197.92
—
193.79
59.56
—
Gross margin %
99.85
98.8
100
100
100
398.8
Operating margin %
48.95
-287
323.1
165.27
25.59
226.96
EBITDA margin %
88.77
-34.3
32.18
66.75
88.86
153.49
Net margin %
50.86
-502.23
311.07
162.99
23.09
-5.08
Liquidity ratios
Quick ratio
3.69
3.92
3.11
5.02
5.02
17.07
Current ratio
3.75
3.92
3.28
5.25
5.22
17.68
Inventory turnover
0.08
0.14
0
0
0
0.14
Asset turnover
0.48
0.07
0.05
0.09
0.28
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.96
0.61
0.74
0.74
0.48
2.58
EBIT per share
1.53
-0.14
0.04
0.2
0.99
1.1
EBITDA per share
1.56
-0.11
0.07
0.24
1.02
1.22
Total debt per share
—
—
—
—
—
—
Cash per share
2.86
2.92
2.31
2.07
1.27
8.57
Net current asset value per share
3.53
3.47
2.89
3.25
3.67
13.28
Tangible book value per share
1.91
1.85
1.26
0.74
1.06
4.91
Working capital per share
2.59
2.59
2.01
2.63
2.96
10.19
Book value per share
1.91
1.85
1.26
0.74
1.06
4.91
Nouvelles
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
L’action MacroGenics chute après une suspension clinique partielle de la FDA
MacroGenics stock falls after FDA places partial clinical hold
Pourquoi l'action de MacroGenics baisse-t-elle mardi ? | Benzinga France
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
Le BPA de MacroGenics Inc a dépassé les attentes de 0,68$, le CA a surpassé les prévisions
MacroGenics Inc earnings beat by $0.68, revenue topped estimates
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?